PUBLISHER: Grand View Research | PRODUCT CODE: 2040813
PUBLISHER: Grand View Research | PRODUCT CODE: 2040813
The global animal vaccines market size was estimated at USD 14.8 billion in 2025 and is projected to reach USD 32.4 billion by 2033, growing at a CAGR of 10.5% from 2026 to 2033. Some of the factors driving market growth are increasing cattle disease outbreaks, rising advancements in innovative therapies, and growing emphasis on the One Health approach & zoonotic disease prevention.
The increasing frequency and severity of livestock disease outbreaks are significantly driving demand for animal vaccines globally. Some of the diseases, such as foot-and-mouth disease (FMD), avian influenza, African swine fever, and lumpy skin disease, have led to substantial economic losses and disruptions in food supply chains. According to a report, African Swine Fever caused over USD112.5 billion in losses during 2019, while Foot-and-Mouth Disease results in annual losses of USD21 billion, highlighting the significant economic burden of livestock diseases globally. In addition, governments and international organizations are implementing large-scale immunization programs to control outbreaks and prevent cross-border disease transmission. In addition, rising global trade of livestock products has increased the need for stringent biosecurity and vaccination protocols. This trend is particularly prominent in developing economies, where livestock farming is a critical source of livelihood.
In addition, the emergence of mRNA and next-generation vaccine technologies is transforming the market by enabling faster, more efficient, and targeted vaccine development. These mRNA-based platforms allow rapid design and scalability, making them highly effective in responding to emerging and mutating pathogens, unlike traditional vaccines. For instance, in July 2025, an mRNA FMD vaccine was developed with Friedrich-Loeffler-Institut that demonstrated full protection in cattle and reduced virus transmission, highlighting its effectiveness and advantages over traditional vaccine production methods. These advanced vaccines offer improved safety profiles and enhanced immune responses across companion and livestock animals. In addition, biopharmaceutical companies are investing in RNA-based, recombinant, and vector-based vaccines in large numbers to address complex and previously unmet veterinary needs. Furthermore, the integration of advanced manufacturing technologies supports large-scale production and commercialization.
Furthermore, growing emphasis on the One Health approach, which integrates human, animal, and environmental health, is a key market driver. Many of the emerging infectious diseases are zoonotic in nature, and preventing disease transmission from animals to humans has become a global priority. According to the CDC report of April 2025, scientists estimated more than 60% of known human infectious diseases originate from animals, whereas about 75% of emerging infections are zoonotic, highlighting the critical role of animal health management and vaccination. Thus, vaccination of animals plays a crucial role in reducing the risk of zoonotic outbreaks, safeguarding public health, and minimizing economic losses. In addition, governments, health organizations, and veterinary stakeholders are collaborating in large numbers to implement comprehensive immunization strategies and surveillance systems. For instance, in August 2025, the Pirbright Institute and CPI partnered to advance RNA livestock vaccines, accelerating innovation, scalable production, and rapid disease response capabilities. As awareness and regulatory support increase, the focus on preventive animal healthcare is strengthening, thereby driving sustained demand for vaccines.
Global Animal Vaccines Market Report Segmentation
This report forecasts revenue growth at global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the global animal vaccines market report based on product, animal, route of administration, distribution channel, and region: